eprobemide eprobemide eprobemide (inn) is a pharmaceutical drug that was used as an antidepressant in russia (under the brand name бефол/befol). it is a non-competitive reversible inhibitor of monoamine oxidase a that exhibits selective action on serotonin deamination. eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. its registration was cancelled on december 30, 2003. eprobemideclinical datatrade namesbefol (ru)other namesbefolroutes ofadministrationorallegal statuslegal status in general: ℞ (prescription only) identifiers iupac name 4-chloro-n-benzamide cas number87940-60-1pubchem cid65659chemspider59094uniiurx5f7rderchemblchembl2104298comptox dashboard (epa)dtxsid3046409 chemical and physical dataformulac14h19cln2o2molar mass282.77 g·mol−13d model (jsmol)interactive image smiles c1coccn1cccnc(=o)c2=cc=c(c=c2)cl inchi inchi=1s/c14h19cln2o2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5h,1,6-11h2,(h,16,18)key:yyfgragnyhywez-uhfffaoysa-n